---
title: "Hims & Hers Insiders Sell $47 Million — Three of Four Exit to Zero Shares"
type: news
slug: hims-and-hers-insiders-sell-47-million-three-of-four-exit-zero-2026
canonical_url: https://13finsight.com/news/hims-and-hers-insiders-sell-47-million-three-of-four-exit-zero-2026
published_at: 2026-02-28T21:31:42.382Z
updated_at: 2026-02-28T21:31:43.156Z
author: Alex Rivera
author_title: Breaking News Editor
author_url: https://13finsight.com/authors/alex-rivera
word_count: 337
locale: en
source: 13F Insight
---

# Hims & Hers Insiders Sell $47 Million — Three of Four Exit to Zero Shares

> Three of four filing insiders at Hims & Hers Health have sold down to zero shares. The PAO, Chief Policy Officer, and CMO have all completely exited while the COO continues selling.

Three of four recently filing insiders at Hims & Hers Health (HIMS) have sold down to zero shares, generating a combined $47.4 million in career stock sales. The telehealth company — which has attracted attention for its compounded GLP-1 weight loss offerings — is seeing a broad insider exodus. COO Leads the Dollar Volume Chief Operating Officer Michael Chi has generated the largest proceeds at $35.5 million across 262 transactions. Unlike his colleagues, Chi still holds shares — but the volume of selling (262 transactions) suggests systematic, ongoing liquidation. His most recent $1.4 million in sales continues the pattern. Three Complete Exits InsiderTitleCareer SalesTransactionsShares After Michael ChiChief Operating Officer$35.5M262Reduced Patrick Harrison CarrollChief Medical Officer$6.5M1370 Irene BecklundPrincipal Accounting Officer$4.6M2790 Deborah M. AutorChief Policy Officer$0.8M290 The CMO Walks Away Chief Medical Officer Patrick Harrison Carroll sold $6.5 million across 137 transactions before exiting completely with $4.9 million in recent sales. For the top medical executive at a health-focused telehealth company to hold zero shares is particularly notable — Carroll is the person ultimately responsible for Hims & Hers' clinical approach and product safety. 279 Transactions, Zero Shares PAO Irene Becklund filed an extraordinary 279 transactions generating $4.6 million, with her final $1.7 million in recent sales bringing her to zero. Chief Policy Officer Deborah M. Autor — the executive navigating Hims & Hers through its regulatory challenges — sold $0.8 million across 29 transactions, also exiting completely. The GLP-1 Question Hims & Hers has become one of the most debated stocks in the market. The company's entry into compounded semaglutide (the active ingredient in Ozempic/Wegovy) attracted millions of customers — but the FDA's recent moves against compounded GLP-1 drugs have created significant regulatory uncertainty. When the Chief Medical Officer, the Chief Policy Officer (who handles regulatory strategy), and the Principal Accounting Officer all sell to zero shares, the signal goes beyond routine diversification. These are the executives closest to the regulatory and financial reality of the business. Monitor all Hims & Hers insider activity on the HIMS stock page.

---

Source: 13F Insight — https://13finsight.com/news/hims-and-hers-insiders-sell-47-million-three-of-four-exit-zero-2026
Author: Alex Rivera — https://13finsight.com/authors/alex-rivera
Last updated: 2026-02-28T21:31:43.156Z